SCHEMBL6971663

SCHEMBL6971663

Cc1cc(-n2ccnc2)c2cccc(OCc3c(Cl)ccc([N+](=O)[O-])c3Cl)c2n1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BDKRB2 P30411 15/20 0.69
RORC P51449 4/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644732 0.84 RORC (0.49) BDKRB2RORC
SCHEMBL7748383 0.83 BDKRB2 (0.51) BDKRB2RORC
SCHEMBL1563126 0.83 BDKRB2 (0.82) BDKRB2RORC
SCHEMBL13145207 0.82 BDKRB2 (0.79) BDKRB2RORC
SCHEMBL1563888 0.82 BDKRB2 (1.00) BDKRB2
SCHEMBL7748533 0.81 RORC (0.47) BDKRB2RORC
SCHEMBL6639746 0.81 BDKRB2 (0.48) BDKRB2RORC
SCHEMBL7072602 0.81 RORC (0.74) BDKRB2RORC
Hydrochloric Acid SCHEMBL6958840 0.81 BDKRB2 (0.69) BDKRB2RORC
SCHEMBL7749686 0.81 BDKRB2 (0.49) BDKRB2RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900203-B1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-03-19 EP disclosed
US-6083959-A BRADYKININ ANTAGONISTS; FOR THE PREVENTION AND/OR THE TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0900203-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 EP disclosed
WO-1997041104-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-06 WO disclosed